Baird Medical swings to six-month net income of $13,499; revenue rises 25% to $9.92 million in six months ended June 30, 2026

• Baird Medical posted net income of US$ 13,499 for the six months ended June 30, 2026, swinging from a net loss.
• Revenue rose 25% to US$ 9.92 million, while loss from operations turned to income from operations of US$ 846,806.
• Technology licensees contributed revenue of US$ 4.8 million, compared with no revenue in the prior-year period.
• Net cash provided by operating activities was US$ 2.46 million, turning from net cash used in operating activities.
• Cash was US$ 138,551 and restricted cash was US$ 150,532 as of June 30, 2026; working capital was US$ 10.2 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Baird Medical Investment Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-112109), on September 30, 2026, and is solely responsible for the information contained therein.